High-Content Screening for the Detection of Drug-Induced Oxidative Stress in Liver Cells

MaríaTeresa Donato1,2, Laia Tolosa1

  • 1Unidad de Hepatología Experimental, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.

Insights

Drug-induced liver injury (DILI) is a significant challenge in drug development. High-content screening of oxidative stress in liver cells offers a powerful method to detect early DILI mechanisms, improving drug safety.

Area of Science:

  • Toxicology
  • Pharmacology
  • Biochemistry

Background:

  • Drug-induced liver injury (DILI) is a primary reason for drug development failures and safety warnings.
  • Oxidative damage from enhanced reactive oxygen species (ROS) is a key mechanism in DILI.
  • In vitro cell-based assays are crucial for early drug safety assessment.

Purpose of the Study:

  • To review the utility of in vitro high-content screening (HCS) for DILI risk assessment.
  • To evaluate methods for assessing drug-induced oxidative stress in hepatic cells.
  • To highlight HCS's role in identifying pre-lethal DILI mechanisms.

Main Methods:

  • Review of in vitro high-content screening technologies.
  • Evaluation of oxidative stress detection in drug-treated hepatic cells.
  • Focus on identifying early, pre-cytotoxic DILI events.

Main Results:

  • High-content screening effectively identifies drug mechanisms of injury.
  • Oxidative stress assessment in hepatic cells is feasible using HCS.
  • HCS can detect pre-lethal DILI indicators.

Conclusions:

  • In vitro HCS is a valuable tool for drug safety evaluation.
  • Assessing oxidative stress via HCS aids in understanding DILI.
  • This approach enhances predictive toxicology for safer drug development.

Related Concept Videos